Our investigation underscores the significant protective effects of PAD2 inhibition using selective inhibitors AFM32a and AFM41a, particularly AFM41a, against PA pneumonia-induced sepsis, as evidenced by the remarkable improvement in survival rates and the notable reduction in bacterial dissemination within the lungs. Here, PADI2 is linked to Sepsis.